HIRST; Kim Louise

Patent Applications and Registrations

Patent applications and USPTO patent grants for HIRST; Kim Louise.The latest application filed is for "amino quinazoline derivatives as p2x3 inhibitors".

Company Profile

9.13.18

HIRST; Kim Louise - Parma IT
HIRST; Kim Louise - Saffron Walden GB
HIRST; Kim Louise - Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amino Quinazoline Derivatives As P2x3 Inhibitors App 20220227749 - BRUNO; Paolo ; et al.	2022-07-21
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20220106287 - CHESSARI; Gianni ; et al.	2022-04-07
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 11,261,171 - Chessari , et al. March 1, 2	2022-03-01
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20210276984 - CHESSARI; Gianni ; et al.	2021-09-09
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,981,898 - Chessari , et al. April 20, 2	2021-04-20
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction And Process For Making Them App 20210101887 - HOWARD; Steven ; et al.	2021-04-08
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200247789 - Kind Code	2020-08-06
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200079761 - CHESSARI; Gianni ; et al.	2020-03-12
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,544,132 - Chessari , et al. Ja	2020-01-28
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 10,526,311 - Chessari , et al. J	2020-01-07
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190055215 - CHESSARI; Gianni ; et al.	2019-02-21
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190016708 - CHESSARI; Gianni ; et al.	2019-01-17
Fused Imidazole Compounds App 20180289718 - SAITO; Tetsuji ; et al.	2018-10-11
Fused imidazole compounds Grant 10,016,439 - Saito , et al. July 10, 2	2018-07-10
Fused Imidazole Compounds App 20160331757 - SAITO; Tetsuji ; et al.	2016-11-17
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 9,006,237 - Andrews , et al. April 14, 2	2015-04-14
Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases App 20120232075 - Andrews; Martin James Inglis ; et al.	2012-09-13
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 8,178,530 - Andrews , et al. May 15, 2	2012-05-15
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 8,173,656 - Andrews , et al. May 8, 2	2012-05-08
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 8,148,369 - Andrews , et al. April 3, 2	2012-04-03
Imidazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20110218178 - Andrews; Martin James Inglis ; et al.	2011-09-08
Triazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20110178067 - Andrews; Martin James Inglis ; et al.	2011-07-21
Imidazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20110092497 - Andrews; Martin James Inglis ; et al.	2011-04-21
Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 7,915,256 - Andrews , et al. March 29, 2	2011-03-29
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 7,893,058 - Andrews , et al. February 22, 2	2011-02-22
Triazolopyrazine Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases App 20100298300 - Andrews; Martin James Inglis ; et al.	2010-11-25
Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 7,501,411 - Andrews , et al. March 10, 2	2009-03-10
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases App 20090012078 - Andrews; Martin James Inglis ; et al.	2009-01-08
Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases App 20080090818 - Andrews; Martin James Inglis ; et al.	2008-04-17
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases App 20070281943 - Andrews; Martin James Inglis ; et al.	2007-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.